Viking Therapeutics, Inc. Common Stock (NASDAQ: VKTX) last traded at $33.89, down 1.37% on the session. The quote above updates while this page is open; the figures below are drawn from Viking Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Viking Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker VKTX. Its market capitalisation is $3.95 billion.
Valuation measures for Viking Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.95B |
|---|---|
| Enterprise value | $3.94B |
| Price / book | 9.68 |
| Beta | 1.15 |
Trailing-twelve-month figures tagged in Viking Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$534.80M |
| EPS (TTM) | -$4.67 |
| Return on equity | -130.98% |
| Cash | $125.75M |
Range and volume for VKTX over the past 52 weeks.
| 52-week high | $43.15 |
|---|---|
| 52-week low | $22.96 |
| Volume | 1.47M |
| Average volume | 2.26M |
| Previous close | $34.36 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.